Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors

Bioorg Med Chem Lett. 2018 May 1;28(8):1320-1323. doi: 10.1016/j.bmcl.2018.03.017. Epub 2018 Mar 6.

Abstract

In this study, a series of carbazole-rhodanine conjugates was synthesized and evaluated for their Topoisomerase II inhibition potency as well as cytotoxicity against a panel of four human cancer cell lines. Among these thirteen compounds, 3a, 3b, 3g, and 3h possessed Topoisomerase II inhibition potency at 20 μM. Mechanism study revealed that these compounds may function as Topo II catalytic inhibitors. It was found that the electron-withdrawing groups on the phenyl ring of compounds played an important role on enhancing both enzyme inhibition and cytotoxicity.

Keywords: Carbazole; Cytotoxic; Hybrid molecule; Rhodanine; Topoisomerase II.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology*
  • Carbazoles / chemical synthesis
  • Carbazoles / pharmacology*
  • Cell Line, Tumor
  • DNA Topoisomerases, Type II / metabolism*
  • Drug Screening Assays, Antitumor
  • Etoposide / pharmacology
  • Humans
  • Intercalating Agents / chemical synthesis
  • Intercalating Agents / pharmacology
  • Rhodanine / analogs & derivatives*
  • Rhodanine / chemical synthesis
  • Rhodanine / pharmacology*
  • Topoisomerase II Inhibitors / chemical synthesis
  • Topoisomerase II Inhibitors / pharmacology*

Substances

  • Antineoplastic Agents
  • Carbazoles
  • Intercalating Agents
  • Topoisomerase II Inhibitors
  • Etoposide
  • Rhodanine
  • DNA Topoisomerases, Type II